covid19-review
covid19-review copied to clipboard
greenelab
A collaborative review of the emerging COVID-19 literature. Join the chat here:
Hello interested contributors! Welcome to the `covid19-review` project. Our goal here is to provide an up-to-date perspective on the current peer reviewed and preprinted literature around diagnostics and therapeutics relevant...
Two new therapeutics that should be added to the pharmaceuticals manuscript: - MAb from AstraZeneca: https://www.astrazeneca.com/media-centre/press-releases/2021/azd7442-prophylaxis-trial-met-primary-endpoint.html - Antiviral from Merck: https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/
In this study, the authors surveyed a large number of surfaces to see if they could amplify evidence of human and SARS-CoV-2 genomes. They found lots of evidence of humans,...
May want to look into this when going through evolution section
May want to consider adding to evolution depending on how the literature looks
Follow up to #1038. I'll work on the external resources workflow to re-enable the manuscript stats when I make some other minor changes.
The first manuscript (nutraceuticals) has been published in _mSystems_: https://doi.org/10.1128/mSystems.00122-21 This is an exciting milestone. However, I noticed that the consortium members are listed in an odd way in the...
Title: Please edit the title to add the name of the paper after the colon. # General Information ## Please paste a link to the paper or a citation here:...
This is a bit preliminary, but I wanted to create a space to organize. There are a few sections that we should probably add to the new standalone vaccine paper:...
Title: The Origins of SARS-CoV-2: A Critical Review # General Information ## Please paste a link to the paper or a citation here: Link: https://doi.org/10.1016/j.cell.2021.08.017 ## What is the paper's...